Syndopa CR 125 Tablet is used to manage the motor symptoms of Parkinson's disease in adults, including tremors, muscle stiffness, and slowness of movement (bradykinesia), helping to improve motor control and support day-to-day functioning.
It combines levodopa (100 mg) and carbidopa (25 mg) in a controlled-release formulation. Swallow it whole; do not crush or chew, as this destroys the controlled-release action. Take it as prescribed; do not stop it suddenly.
Keeping to all monitoring appointments, following a regular dosing schedule, and staying physically active as advised support stable symptom control alongside this medicine.
Tell your doctor about any history of mental health concerns, glaucoma, or irregular heart rhythm before starting. Report sudden extreme drowsiness, hallucinations, confusion, unusual involuntary movements, or significant mood changes immediately, as your dose may need adjustment.











































































